Sequent Scientific Profit & Loss Annual

Trade
BSE: 512529 | NSE: SEQUENT | ISIN: INE807F01027 | Sector: Biotechnology & Drugs
117.00 +0.85 (0.73%)Updated : 18 May 2024
Fiscal Period2024202320222021
Period End DateMar 24Mar 23Mar 22Mar 21
Revenue 1,369.731,420.911,412.821,361.62
Total Revenue 1,369.731,420.911,412.821,361.62
Costof Revenue Total 759.75906.09793.00751.67
Gross Profit 609.98514.82619.82609.94
Selling/ General/ Admin Expenses Total 250.57448.40231.37370.63
Depreciation/ Amortization 61.5455.6951.5450.60
Unusual Expense( Income) 17.3965.940.008.82
Other Operating Expenses Total 290.1826.07279.0523.03
Total Operating Expense 1,379.431,502.201,354.961,204.75
Operating Income -9.70-81.2957.86156.87
Interest Inc( Exp) Net- Non- Op Total -559.04-556.99-157.74-192.53
Other Net 10.96-2.7110.85-1.68
Net Income Before Taxes -54.65-137.6652.93136.63
Provisionfor Income Taxes -25.03-15.688.1732.18
Net Income After Taxes -29.61-121.9844.76104.45
Minority Interest -6.260.82-3.81-9.01
Net Income Before Extra Items -35.87-121.1640.9695.44
Net Income -35.87-121.1640.9695.44
Income Availableto Com Excl Extra Ord -35.87-121.1640.9695.44
Income Availableto Com Incl Extra Ord -35.87-121.1640.9695.44
Diluted Net Income -35.87-121.1640.9695.44
Diluted Weighted Average Shares 24.9124.8524.8224.79
Diluted EPS Excluding Extra Ord Items -1.44-4.881.653.85
Diluted Normalized EPS -0.99-3.201.654.10
Gain( Loss)on Saleof Assets -20.42-6.98
DPS- Common Stock Primary Issue --0.000.50
*All figures in crores except per share values
Recommended For You
Trending Stocks
2,495.00+49.80(2.04%)
953.75+8.00(0.85%)
2,504.50-9.95 (-0.40%)
12,600.00-43.85 (-0.35%)
HomeMarketsPremiumFor youGet App